Journals / Haseki Tıp Bülteni / 2012 / Cilt: 50 - Sayı: 3

Minimal invasive methods in the treatment of benign prostate hyperplasia

Benign prostat hiperplazisi tedavisinde uygulanan minimal invaziv yöntemler

Pages
76–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, minimal invasive surgical methods were evaluated in the light of current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Several methods of surgical treatment of benign prostatic hyperplasia have been described.
📊
Key Findings & Data:Transurethral resection of the prostate, which was first performed in 1932, still remains the gold standard for surgical treatment.
💡
Conclusion & Impact:In this review, minimal invasive surgical methods were evaluated in the light of current literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Several methods of surgical treatment of benign prostatic hyperplasia have been described. Transurethral resection of the prostate, which was first performed in 1932, still remains the gold standard for surgical treatment. However, beside the risk of bleeding and TUR syndrome, transurethral resection of the prostate has some disadvantages such as need for anesthesia, hospitalization and prolonged catheterization. Because of these disadvantages, minimally invasive surgical methods have come to order more commonly, especially within the last decade. Minimally invasive methods include transurethral microwave therapy, transurethral needle ablation, laser treatments, transurethral ethanol ablation of the prostate, and high-intensity focused ultrasound. These techniques provided significant decreases in the risk of bleeding and TUR syndrome. They are superior to transurethral resection of the prostate in terms of hospitalization and catheterization time. In addition, short-term results of some techniques are comparable to transurethral resection of the prostate. However, because of the fact that the efficacy and safety of transurethral resection of the prostate have been proven for the purposes of long-term results, there is no any minimally invasive surgical method can take the place of transurethral resection of the prostate. In this review, minimal invasive surgical methods were evaluated in the light of current literature.

Özet

Benign prostat hiperplazisi tedavisinde günümüze kadar pek çok teknik tanımlanmıştır. İlk olarak 1932’de uygulanan transüretral prostat rezeksiyonu halen altın standart cerrahi teknik olarak kabul edilmektedir. Ancak transüretral prostat rezeksiyonunun kanama ve TUR sendromu gibi risklerinin yanında uzun kateterizasyon süresi, anestezi ve hastanede kalmayı gerektirmesi gibi dezavantajları bulunmaktadır. Bu dezavantajlar nedeni ile özellikle son dekatta minimal invaziv cerrahi yöntemler daha fazla gündeme gelmiştir. Başlıca minimal invaziv yöntemler transüretral mikrodalga tedavisi, transüretral iğne ablasyonu, laser tedavileri, transüretral etanol ablasyonu ve yüksek yoğunluklu ultrason tedavisi olarak sayılabilir. Bu yöntemler kanama, TUR sendromu gibi risklerde ciddi azalmalar sağlamışlardır. Hastanede kalış ve kataterizasyon süreleri açısından transüretral prostat rezeksiyonundan üstündürler. Ayrıca bazı minimal invaziv yöntemlerin kısa dönem sonuçları transüretral prostat rezeksiyonu ile karşılaştırılabilir düzeydedir. Ancak uzun dönem sonuçlar açısından transüretral prostat rezeksiyonunun etkinlik ve güvenilirliği tam olarak kanıtlandığından henüz transüretral prostat rezeksiyonunun yerini alabilecek bir minimal invaziv yöntem bulunmamaktadır. Bu derlemede benign prostat hiperplazisi tedavisinde uygulanan minimal invaziv cerrahi yöntemler güncel literatür eşliğinde incelenmiştir.

🔖

Cite This Article

ERBİN, A., BERBEROĞLU, A. Y., SARILAR, Ö., BİNBAY, M., MÜSLÜMANOĞLU, A. Y. (2012). Minimal invasive methods in the treatment of benign prostate hyperplasia. Haseki Tıp Bülteni, Cilt: 50 - Sayı: 3, 76–80. https://ajindex.com/articles/267977

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Roehrborn CG, Bartsch G, Kirby R, et al. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 2001;58:642-50
  2. EAU Guidelines on the Treatment of Non-neurogenic Male LUTS, 2012 Edition
  3. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005;174:1887-91
  4. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83:227-37
  5. Lourenco T, Armstrong N, N’Dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008;12:1-146, 169-515
  6. Hahn RG. Smoking increases the risk of large scale fluid absorption during transurethral prostatic resection. J Urol 2001;166:162-5
  7. Blute ML, Tomera KM, Hellerstein DK, et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol 1993;150:1591-6
  8. Hoffman RM, Monga M, Elliot S, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2007;17:CD004135
  9. Mattiasson A, Wagrell L, Schelin S, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2007;69:91-6
  10. Gravas S, Laguna P, Ehrnebo M, et al. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy. J Urol 2005;174:1002-6
  11. De la Rosette JJ, Laguna MP, Gravas S, de Wildt MJ. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia? J Endourolog 2003;17:245-51
  12. D’Ancona FC, van der Bij AK, Francisca EA, et al. Results of high energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anaesthiologists operative risk classification. Urology 1999;53:322-8
  13. Roehrborn CG, Issa MM, Bruskewitz RC, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S study. Urology 1998;51: